Skip to content

Milestones

February 2011
Company formation
February 2011
May 2017
Series A financing
May 2017
September 2018
Convertible note financing
September 2018
August 2019
Convertible note financing
August 2019
October 2019
Australian regulatory approval for Phase 1 study in patients with retinal detachment
October 2019
October 2019
First patient dosed, first in human clinical trial in retinal detachment
October 2019
December 2019
ONL1204 patent issued in US
December 2019